Literature DB >> 23507918

Hepatitis E virus infection.

Nassim Kamar1, Jacques Izopet, Lionel Rostaing.   

Abstract

PURPOSE OF REVIEW: The spectrum of hepatitis E virus (HEV) infection has changed over the past 2 years, especially in the developed world. Herein, we review the progress made in studying the epidemiology, hepatic, and extrahepatic manifestations, and the treatment of HEV infection, over the past 2 years. RECENT
FINDINGS: HEV infection is an underdiagnosed disease because of the use of low-sensitivity serological assays. In addition to the four known genotypes, other new genotypes have also been recently described. HEV infection is not only a self-limiting disease but it can also evolve to chronic hepatitis and cirrhosis in organ transplant patients, hematological patients receiving chemotherapy, and HIV patients. HEV can also cause extrahepatic manifestations, such as neurological symptoms, kidney injury, and hematological disorders. Pegylated interferon and ribavirin have been found to effectively treat HEV infection.
SUMMARY: HEV is a worldwide disease that can cause hepatic and extrahepatic manifestations.

Entities:  

Mesh:

Year:  2013        PMID: 23507918     DOI: 10.1097/MOG.0b013e32835ff238

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  9 in total

1.  An Epidemiologic Investigation of a Case of Acute Hepatitis E.

Authors:  Souvik Sarkar; Elenita M Rivera; Ronald E Engle; Hanh T Nguyen; Cathy A Schechterly; Harvey J Alter; T Jake Liang; Robert H Purcell; Jay H Hoofnagle; Marc G Ghany
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

2.  Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors.

Authors:  T Vollmer; C Knabbe; J Dreier
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

Review 3.  Hepatitis E: Discovery, global impact, control and cure.

Authors:  Mohammad S Khuroo; Mehnaaz S Khuroo; Naira S Khuroo
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

4.  Human immunodeficiency virus and liver disease: An update.

Authors:  Kenneth E Sherman; Juergen Rockstroh; David Thomas
Journal:  Hepatology       Date:  2015-10-20       Impact factor: 17.425

5.  Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis.

Authors:  Mulat Dagnew; Amare Belachew; Moges Tiruneh; Feleke Moges
Journal:  BMC Infect Dis       Date:  2019-06-13       Impact factor: 3.090

6.  Hepatitis E virus infection among patients with altered levels of alanine aminotransferase.

Authors:  Danielle Dias Conte; Luciano Kleber de Souza Luna; Amanda Passarini; Vitória Rodrigues Guimarães Alves; Debora Bellini Caldeira; Jessica Santiago Cruz; Viviane Almeida Gouveia; Nancy Bellei; Celso F H Granato
Journal:  Braz J Infect Dis       Date:  2021-11-27       Impact factor: 3.257

7.  Seroepidemiology of hepatitis e virus infection in general population in rural durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sanchez-Anguiano; Jesus Hernandez-Tinoco
Journal:  Hepat Mon       Date:  2014-06-01       Impact factor: 0.660

8.  Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease.

Authors:  Mohammad Khalid Parvez; Azmat Ali Khan
Journal:  Virus Res       Date:  2013-12-07       Impact factor: 3.303

9.  Whole Genome Sequencing Characterization of HEV3-e and HEV3-f Subtypes among the Wild Boar Population in the Abruzzo Region, Italy: First Report.

Authors:  Giuseppe Aprea; Silvia Scattolini; Daniela D'Angelantonio; Alexandra Chiaverini; Valeria Di Lollo; Sabrina Olivieri; Maurilia Marcacci; Iolanda Mangone; Stefania Salucci; Salvatore Antoci; Cesare Cammà; Adriano Di Pasquale; Giacomo Migliorati; Francesco Pomilio
Journal:  Microorganisms       Date:  2020-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.